Therefore, our previous study illustrates that interventions solely targeting CD4 T cell subsets (T helper and Treg) may not be able to revert T1D, at least in our humanized T1D mouse model (Imam et al., 2019). This evidence concerns the gene CD4 and type 1 diabetes mellitus.